217 related articles for article (PubMed ID: 19523210)
1. Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Desjardins S; Beauparlant JC; Labrie Y; Ouellette G; Durocher F;
BMC Cancer; 2009 Jun; 9():181. PubMed ID: 19523210
[TBL] [Abstract][Full Text] [Related]
2. Analysis of GADD45A sequence variations in French Canadian families with high risk of breast cancer.
Desjardins S; Ouellette G; Labrie Y; Simard J; ; Durocher F
J Hum Genet; 2008; 53(6):490-498. PubMed ID: 18350249
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
4. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
5. [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].
Pohlreich P; Kleibl Z; Kleiblová P; Janatová M; Soukupová J; Macháčková E; Házová J; Vašíčková P; Sťahlová Hrabincová E; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2012; 25 Suppl():S59-66. PubMed ID: 22920209
[TBL] [Abstract][Full Text] [Related]
6. Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.
Guénard F; Labrie Y; Ouellette G; Beauparlant CJ; Durocher F;
J Hum Genet; 2009 Mar; 54(3):152-61. PubMed ID: 19197335
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ZNF350/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1/2 French Canadian breast cancer families.
Plourde KV; Labrie Y; Desjardins S; Belleau P; Ouellette G; Durocher F;
J Hum Genet; 2013 Feb; 58(2):59-66. PubMed ID: 23151675
[TBL] [Abstract][Full Text] [Related]
8. RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
He M; Di GH; Cao AY; Hu Z; Jin W; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 May; 133(1):111-6. PubMed ID: 21811815
[TBL] [Abstract][Full Text] [Related]
9. Detecting Variants in the NBN Gene While Testing for Hereditary Breast Cancer: What to Do Next?
Zuntini R; Bonora E; Pradella LM; Amato LB; Vidone M; De Fanti S; Catucci I; Cortesi L; Medici V; Ferrari S; Gasparre G; Peterlongo P; Sazzini M; Turchetti D
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072463
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families.
Guénard F; Labrie Y; Ouellette G; Joly Beauparlant C; Simard J; ; Durocher F
J Hum Genet; 2008; 53(7):579. PubMed ID: 18414782
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
[TBL] [Abstract][Full Text] [Related]
13. Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line.
Schröder-Heurich B; Bogdanova N; Wieland B; Xie X; Noskowicz M; Park-Simon TW; Hillemanns P; Christiansen H; Dörk T
BMC Cancer; 2014 Jun; 14():434. PubMed ID: 24928521
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Guénard F; Pedneault CS; Ouellette G; Labrie Y; Simard J; ; Durocher F
Genet Test Mol Biomarkers; 2010 Aug; 14(4):515-26. PubMed ID: 20722467
[TBL] [Abstract][Full Text] [Related]
15. Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families.
Guénard F; Labrie Y; Ouellette G; Beauparlant CJ; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Durocher F;
Fam Cancer; 2007; 6(4):483-90. PubMed ID: 17636424
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families.
Tesoriero AA; Wong EM; Jenkins MA; Hopper JL; Brown MA; Chenevix-Trench G; Spurdle AB; Southey MC;
Hum Mutat; 2005 Nov; 26(5):495. PubMed ID: 16211554
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.
Kim H; Cho DY; Choi DH; Jung GH; Shin I; Park W; Huh SJ; Kim SW; Park SK; Lee JW; Nam SJ; Lee JE; Gil WH; Kim SW
Fam Cancer; 2015 Sep; 14(3):365-71. PubMed ID: 25712764
[TBL] [Abstract][Full Text] [Related]
19.
Concolino P; Gelli G; Rizza R; Costella A; Scambia G; Capoluongo E
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336956
[TBL] [Abstract][Full Text] [Related]
20. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
